J7212 Factor viia recomb sevenfact
Also known as: Sevenfact, Factor VIIa recombinant, rFVIIa
Injection of Factor VIIa recombinant Sevenfact (eptacog alfa [activated], recombinant), for hemostasis promotion.
In Plain Language
bleeding control; hemophilia inhibitor treatment
Clinical Context
Used for episodic treatment of bleeding in hemophilia A and B patients with inhibitors, and for other bleeding conditions.
RVU Information
CPT J7212 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7212?
CPT J7212 (Factor viia recomb sevenfact) is a J Codes (Drugs) code. Injection of Factor VIIa recombinant Sevenfact (eptacog alfa [activated], recombinant), for hemostasis promotion.
How is J7212 administered?
CPT J7212 is administered by a healthcare provider, typically via injection or infusion. Used for episodic treatment of bleeding in hemophilia A and B patients with inhibitors, and for other bleeding conditions. It is used by Hematology, Hemophilia Specialty Clinic, Emergency Medicine.
When is CPT J7212 used?
Used for episodic treatment of bleeding in hemophilia A and B patients with inhibitors, and for other bleeding conditions.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.